<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>Clinical Reviews in Bone and Mineral Metabolism via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Clinical Reviews in Bone and Mineral Metabolism' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Clinical+Reviews+in+Bone+and+Mineral+Metabolism&t=Clinical+Reviews+in+Bone+and+Mineral+Metabolism&s=Search&f=source]]></link>
        <lastBuildDate>Sun, 21 Mar 2010 16:41:09 +0100</lastBuildDate>
        <item>
            <title>A Possible Role for Epigenetics in Age-Dependent Bone Diseases</title>
            <link>http://www.medworm.com/index.php?rid=3381593&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F66005650167247g4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Epigenetics, the study of changes in gene expression without alteration of the DNA sequence, has emerged as a promising area
 of research in the field of age-related diseases. Epigenetic processes, mainly DNA methylation and histone acetylation, can
 influence genotypes as a response to environmental and stochastic factors. The aging process is considered to be an accumulation
 of molecular errors, which also affect epigenetic mechanisms and could contribute to the appearance of age-related diseases.
 Based on the role of epigenetics in several age-dependent diseases, in this paper we discuss its possible involvement in age-dependent
 bone diseases such as osteoporosis and rheumatoid arthritis.
 
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12018-0...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3381593</comments>
            <pubDate>Wed, 17 Mar 2010 15:51:42 +0100</pubDate>
            <guid isPermaLink="false">3381593</guid>        </item>
        <item>
            <title>Clinical Tools to Evaluate Bone Strength</title>
            <link>http://www.medworm.com/index.php?rid=3270843&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl620264047h9482q%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Although dual-energy absorptiometry (DXA) has proven its clinical utility, there are many limitations to using areal bone
 mineral density (aBMD) measured by DXA to predict bone strength and fracture risk. Recent advances in imaging techniques including
 quantitative computed tomography (QCT) and magnetic resonance imaging (MRI) have led to non-invasive assessment of bone macro-architecture
 and micro-architecture. Analysis techniques such as finite element (FE) modelling use image data to estimate the ability of
 a bone to carry load, and provide new insight into treatment effects and fracture risk. QCT and MRI can image clinically relevant
 sites such as the lumbar spine and proximal femur. High-resolution peripheral QCT (HR-pQCT) offers superior resolution at
 periph...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3270843</comments>
            <pubDate>Fri, 12 Feb 2010 07:32:42 +0100</pubDate>
            <guid isPermaLink="false">3270843</guid>        </item>
        <item>
            <title>Bone Homeostasis in Intestinal Disorders</title>
            <link>http://www.medworm.com/index.php?rid=3248395&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F14717263l87374r7%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Diagnosis and therapy of osteoporosis associated with gastrointestinal diseases is a remarkable problem. Osteoporosis is most
 common in celiac disease, Crohn’s disease, chronic liver disease, and in postgastrectomy patients. Protocols regarding prevention,
 diagnosis and therapy are based on results gained from patients with osteoporosis in the general population. This review aims
 to summarize the special aspects and most important clinical data regarding the bone loss associated with gastrointestinal
 diseases.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12018-010-9069-zAuthors
		Pál Miheller, Semmelweis University 2nd Department of Medicine Szentkirályi u. 46 H-1088 Budapest HungaryPéter L. Lakatos, Semmelweis University 1st Department of...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3248395</comments>
            <pubDate>Fri, 05 Feb 2010 08:09:48 +0100</pubDate>
            <guid isPermaLink="false">3248395</guid>        </item>
        <item>
            <title>Design and Interpretation of Linkage and Association Studies on Osteoporosis</title>
            <link>http://www.medworm.com/index.php?rid=3248396&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw24p4057j36p25k4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Osteoporosis is a common disease with strong genetic control. Genetic linkage and association studies are the two most popular
 methods used to investigate the genetic basis of osteoporosis. Linkage studies have been successfully used to identify quantitative
 trait loci (QTLs), and association studies have been widely performed to test candidate genes for osteoporosis. In this article,
 we review the design and interpretation of linkage and association studies on osteoporosis.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12018-010-9070-6Authors
		Ting Xu, University of Missouri School of Medicine Kansas City MO 64108 USAYu Cheng, University of Missouri School of Medicine Kansas City MO 64108 USAYan Guo, Xi’an Jiaotong University The Key Laborato...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3248396</comments>
            <pubDate>Thu, 04 Feb 2010 07:01:25 +0100</pubDate>
            <guid isPermaLink="false">3248396</guid>        </item>
        <item>
            <title>Pharmacogenomics of Osteoporosis</title>
            <link>http://www.medworm.com/index.php?rid=3248397&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd1848604n1421317%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Pharmacogenomics and pharmacogenetics are emerging interdisciplinary areas recently defined, respectively as “the investigation
 of variations of DNA and RNA characteristics as related to drug response”, and the study of “the influence of variations in
 DNA sequence on drug efficacy and toxicity”. A major challenge of future genetic studies in complex disorders such as osteoporosis
 is the development of specific genetic tests to identify responders from non-responders as well as to identify patients at
 higher risk to develop adverse reactions. Even though the knowledge of the genetic determinants of bone fragility and fracture
 risk has consistently increased over the past decade and despite the parallel development of multiple drugs with antiresorptive
 or an...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3248397</comments>
            <pubDate>Thu, 04 Feb 2010 07:01:23 +0100</pubDate>
            <guid isPermaLink="false">3248397</guid>        </item>
        <item>
            <title>Genetic Susceptibility in Inflammatory Bowel Disease</title>
            <link>http://www.medworm.com/index.php?rid=3162800&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F180j54329815m428%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The genetic susceptibility is clearly important in the complex inheritance of inflammatory bowel disease (IBD). Furthermore,
 the etiologic basis of the relationship between Crohn’s disease (CD) and ulcerative colitis (UC) is as yet unexplained. The
 strongest evidence supporting the contribution of inherited factors in the pathogenesis of CD and UC comes from concordance
 rates in twin pairs. The development of a linkage map of the human genome with informative microsatellite markers has enabled
 hypothesis-free scanning of the human genome for loci associated with the susceptibility to simple monogenic and polygenic
 diseases. Many susceptibility loci have been implicated in IBD with varying degrees of replication and statistical support.
 Genetic research in IBD ha...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3162800</comments>
            <pubDate>Sat, 09 Jan 2010 08:26:47 +0100</pubDate>
            <guid isPermaLink="false">3162800</guid>        </item>
        <item>
            <title>Identification and Functional Analysis of Regulatory Polymorphisms</title>
            <link>http://www.medworm.com/index.php?rid=3155429&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn7627wh53742259h%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Current models for the genetics of common diseases suggest that diseases are the result of the sum of variants which on their
 own produce a small effect on the disease phenotype. Because of this small effect, common disease variants are very difficult
 to find, even with the application of the powerful new methods for the study of gene variants–disease association. An alternative
 approach based on the functional changes due to the variants is described here. The focus is set on regulatory variants because
 they fit best the current models. Regulatory variants filtered by the application of bioinformatic methods are analysed in
 order to select those best suited for subsequent association studies. No single method can characterize the functional consequences
 of a va...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3155429</comments>
            <pubDate>Wed, 06 Jan 2010 06:55:46 +0100</pubDate>
            <guid isPermaLink="false">3155429</guid>        </item>
        <item>
            <title>Prenatal and Nutritional Influences on Skeletal Development: Lessons from Animal Studies</title>
            <link>http://www.medworm.com/index.php?rid=2991928&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Flun00l1u71272151%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;It is now well established that the onset of adult diseases such as heart disease, stroke, type 2 diabetes and hypertension
 are linked to an adverse uterine growth environment, in particular through maternal nutrition, during development of the individual.
 The geographical distribution of the incidence rate of heart disease is similar to that of osteoporosis. This may indicate
 a link between maternal nutrition during pregnancy and the subsequent risk of developing osteoporosis in the offspring. This
 review summarises what we know to date, from animal models, about maternal nutrition and the subsequent alterations in the
 offspring’s skeletal structure.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12018-009-9065-3Authors
		Stuart A. Lanham, Un...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2991928</comments>
            <pubDate>Thu, 12 Nov 2009 09:09:05 +0100</pubDate>
            <guid isPermaLink="false">2991928</guid>        </item>
        <item>
            <title>T-Scores and Z-Scores</title>
            <link>http://www.medworm.com/index.php?rid=2983962&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F42293q401wm86m7m%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Bone mineral density (BMD) can be measured by a variety of techniques at several skeletal sites. Once measured, the manufacturers’
 software uses the BMD to calculate a T-score and/or Z-score. Both T-scores and Z-scores are derived by comparison to a reference population on a standard deviation scale. The recommended reference group
 for the T-score is a young gender-matched population at peak bone mass, while the Z-score should be derived from an age-matched reference population. T-scores and Z-scores are widely quoted in scientific publications on osteoporosis and BMD studies, and are the values used for DXA diagnostic
 criteria and current clinical guidelines for the management of osteoporosis. Errors in BMD measurement, differences in reference
 populations, and v...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2983962</comments>
            <pubDate>Tue, 10 Nov 2009 07:50:37 +0100</pubDate>
            <guid isPermaLink="false">2983962</guid>        </item>
        <item>
            <title>Dendritic Cell-Associated Osteoclastogenesis and Bone Loss</title>
            <link>http://www.medworm.com/index.php?rid=2897683&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd8k1680781p41647%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The present osteoimmunology paradigm whereby inflammation in the periosseous tissue is significantly associated with an increase
 in osteoclasts (OC) frequency, activity and bone destruction (i.e., inflammation-induced osteoclastogenesis and bone loss)
 has now been fully implemented. We and others have studied the role(s) of dendritic cells (DC) during this process and thereafter
 proposed that, in addition to innate effector functions and their critical role as antigen-presenting cells (APC) involved
 in triggering and orchestrating the adaptive immune responses, they could be directly implicated as osteoclast precursors
 (OCp) during inflammation at the osteo–immune interface [called; DC-derived OC or DDOC]. Further understanding of the role(s)
 of DC in the inflam...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2897683</comments>
            <pubDate>Tue, 13 Oct 2009 10:54:00 +0100</pubDate>
            <guid isPermaLink="false">2897683</guid>        </item>
        <item>
            <title>Vitamin D, Immunity and Human Disease</title>
            <link>http://www.medworm.com/index.php?rid=2870944&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fmj37887p88285318%2F</link>
            <description>This article will review the effects of vitamin D on innate immune responses with specific emphasis on
 the autocrine induction of antibacterial responses in macrophages, and the regulation of dendritic cell-mediated antigen presentation.
 The impact of vitamin D on adaptive immunity will also be reviewed, focusing on the effects of vitamin D on T-cell function,
 particularly the induction of regulatory T-cells. The review will also explore the impact of vitamin D deficiency on these
 facets of immune function, as well as the possible benefits of vitamin D supplementation. Finally, the review will also include
 an appraisal of human diseases such as infection and autoimmune disease that may be substantially influenced by vitamin D-dependent
 regulation of human immunity.
 
	Content Type Jo...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2870944</comments>
            <pubDate>Tue, 06 Oct 2009 12:57:58 +0100</pubDate>
            <guid isPermaLink="false">2870944</guid>        </item>
        <item>
            <title>Immunomodulation of Multiple Myeloma Bone Disease</title>
            <link>http://www.medworm.com/index.php?rid=2811973&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F734k6234t5440101%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Multiple myeloma (MM) is a clonal malignancy of terminally differentiated plasma cells. Myeloma patients often have extensive
 skeletal complications, including bone pain, osteolytic lesions and pathological fractures, which represent the major cause
 of morbidity and possible mortality. Osteolysis is due to the uncoupling of bone cell activity, caused by osteoclast activation
 and osteoblast inhibition. Osteoclast biology is dominantly regulated by the RANK/RANKL/OPG axis. A disruption of RANKL/OPG
 ratio, due to the prevalence of RANKL and/or inactivation of OPG, has been reported in MM bone disease by different mechanisms
 involving either malignant plasma cells and/or other cells of immune system. Despite the major involvement of RANKL in MM
 is well documented, a d...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2811973</comments>
            <pubDate>Fri, 18 Sep 2009 06:20:45 +0100</pubDate>
            <guid isPermaLink="false">2811973</guid>        </item>
        <item>
            <title>Osteoclast Formation from Peripheral Blood of Patients with Bone-lytic Diseases</title>
            <link>http://www.medworm.com/index.php?rid=2768083&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fvn18586574673031%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Recent literature indicates that osteoclast formation in vitro from peripheral blood of patients with diseases associated
 with bone loss such as rheumatoid arthritis, osteoporosis, periodontitis and bone metastatic cancer may occur spontaneously
 being independent of addition of osteoclast formation stimulating factors such as macrophage colony forming factor (M-CSF)
 and receptor activator of NFκB ligand (RANKL). This could provide important clues to our understanding on how osteoclast precursors
 are primed within the circulation whilst commuting to the site of ultimate osteoclast differentiation. When comparing the
 various bone-lytic diseases, the common view emerges that accessory cells, such as T- and B-lymphocytes provide osteoclastogenesis
 stimulating factors...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2768083</comments>
            <pubDate>Thu, 03 Sep 2009 06:05:14 +0100</pubDate>
            <guid isPermaLink="false">2768083</guid>        </item>
        <item>
            <title>Immune System and Postmenopausal Bone Loss</title>
            <link>http://www.medworm.com/index.php?rid=2733124&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu82104887j751t4g%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The relation between immune system, estrogen deficiency and postmenopausal bone loss is an intriguing and yet unexplained
 challenge of the past two decades. Here we summarize the evidences that link estrogen deficiency, T and B cells proliferation
 and activation, cytokines production, and bone loss with particular regard to humans.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12018-009-9061-7Authors
		Patrizia D’Amelio, University of Torino Department of Surgical and Medical Disciplines, Section of Gerontology Corso Bramante 88/90 10126 Torino ItalyGiovanni Carlo Isaia, University of Torino Department of Surgical and Medical Disciplines, Section of Gerontology Corso Bramante 88/90 10126 Torino Italy
	

	
		Journal Clinical Reviews in Bone and M...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2733124</comments>
            <pubDate>Mon, 24 Aug 2009 17:40:30 +0100</pubDate>
            <guid isPermaLink="false">2733124</guid>        </item>
        <item>
            <title>Introduction</title>
            <link>http://www.medworm.com/index.php?rid=2722632&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F20u761x4582h3642%2F</link>
            <description>Content Type Journal ArticleCategory IntroductionDOI 10.1007/s12018-009-9060-8Authors
		Patrizia D’Amelio, University of Torino-Italy Department of Surgical and Medical Disciplines, Section of Gerontology Corso Bramante 88/90 10126 Torino Italy
	

	
		Journal Clinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2722632</comments>
            <pubDate>Thu, 20 Aug 2009 09:08:00 +0100</pubDate>
            <guid isPermaLink="false">2722632</guid>        </item>
        <item>
            <title>Vitamin D Regulation of Immune Function: Implications for Bone Loss During Inflammation</title>
            <link>http://www.medworm.com/index.php?rid=2718736&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3706071452427h85%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Although the best known actions of vitamin D involve its regulation of bone mineral homeostasis, actions critical for a healthy
 skeleton, vitamin D exerts its influence on many physiologic processes. One of these processes is the immune system. Both
 the adaptive and innate immune systems are impacted by the active metabolite of vitamin D, 1,25(OH)2D3. In turn, the immune system is now recognized as having a major impact on the skeleton. In this review, I will examine the
 regulation by 1,25(OH)2D3 of immune function, then examine the evidence for such regulation as potential means of ameliorating the bone loss that accompanies
 the inflammatory state.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12018-009-9056-4Authors
		Daniel D. Bikle, Veterans...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2718736</comments>
            <pubDate>Wed, 19 Aug 2009 11:16:00 +0100</pubDate>
            <guid isPermaLink="false">2718736</guid>        </item>
        <item>
            <title>Oral Bisphosphonate-Related Osteonecrosis of the Jaw: Incidence, Clinical Features, Prevention, and Treatment Recommendations</title>
            <link>http://www.medworm.com/index.php?rid=2592845&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr1535xjn74706309%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Biphosphonate-related osteonecrosis of the jaw (BRONJ) is a devastating side effect of oral bisphosphonates associated with
 patient morbidity and high financial burden to health services. BRONJ is usually associated with parenteral use of bisphosphonates
 in oncologic patients, but its incidence among individuals with osteoporosis who take oral bisphosphonates is on the rise.
 In the absence of definitive treatment for BRONJ, every effort should be made toward its prevention. The patients must be
 informed about the extremely small but proven risk of oral BRONJ and be recommended to undergo periodic dental evaluation
 and meticulous oral hygiene. Once BRONJ occurs, long-term antibiotic therapy and superficial curettage may be beneficial.
 
	Content Type Journal Article...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2592845</comments>
            <pubDate>Thu, 09 Jul 2009 13:47:45 +0100</pubDate>
            <guid isPermaLink="false">2592845</guid>        </item>
        <item>
            <title>Fracture Risk Assessment in Clinical Practice: T-scores, FRAX, and Beyond</title>
            <link>http://www.medworm.com/index.php?rid=2568111&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F905783226l972770%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Assessment of fracture risk is a key component in the evaluation of skeletal health and a critical step in determining whether
 to initiate pharmacological therapy to reduce fracture risk. The identification of high risk patients allows clinicians to
 direct limited healthcare resources to those who are most likely to benefit. Bone mineral density (BMD) and clinical risk
 factors (CRFs) for fracture predict fracture risk better than BMD or CRFs alone. Dual-energy X-ray absorptiometry (DXA) is
 a technology for the measurement of BMD to diagnose osteoporosis, assess fracture risk, and monitor the BMD response to therapy.
 Validated CRFs and femoral neck BMD by DXA, when available, provide the input for the World Health Organization fracture risk
 assessment tool (FRAX) t...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2568111</comments>
            <pubDate>Tue, 30 Jun 2009 15:55:21 +0100</pubDate>
            <guid isPermaLink="false">2568111</guid>        </item>
        <item>
            <title>Impact of Diabetes and its Treatment on Bone</title>
            <link>http://www.medworm.com/index.php?rid=2500290&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fgpj13346h511m703%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Type 2 diabetes (T2DM) is associated with increased fracture risk and higher bone density (BMD), suggesting that diabetic
 bone is more fragile for a given density. The changes in bone quality that accompany T2DM are still not fully delineated but
 potential factors include more rapid bone loss, differences in cortical bone and bone structure, and changes in material properties
 of bone collagen due to accumulation of advanced glycation endproducts (AGEs). Increased fracture risk appears to be concentrated
 among patients with longer duration of diabetes while those with recent onset or with impaired glucose tolerance may instead
 be protected from fracture risk. Characteristics of T2DM have contradictory effects on bone strength and fracture risk. Bone
 strength is gen...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2500290</comments>
            <pubDate>Tue, 09 Jun 2009 15:43:19 +0100</pubDate>
            <guid isPermaLink="false">2500290</guid>        </item>
        <item>
            <title>Effects of Feeding on Bone Metabolism</title>
            <link>http://www.medworm.com/index.php?rid=2462353&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F971j9w20668061u8%2F</link>
            <description>In conclusion, bone metabolism is regulated
 by long-term energy balance, acute effects of feeding and dietary composition, and there are likely to be multiple interactions
 between these processes. Some of the endocrine mediators of feeding and bone metabolism have potential as therapeutic agents.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12018-009-9052-8Authors
		J. S. Walsh, Northern General Hospital NIHR Bone Biomedical Research Unit Herries Road Sheffield S5 7AU UKR. Eastell, Northern General Hospital NIHR Bone Biomedical Research Unit Herries Road Sheffield S5 7AU UK
	

	
		Journal Clinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2462353</comments>
            <pubDate>Fri, 05 Jun 2009 09:18:52 +0100</pubDate>
            <guid isPermaLink="false">2462353</guid>        </item>
        <item>
            <title>Bone Assessment in Children: Clinical Relevance and Interpretation</title>
            <link>http://www.medworm.com/index.php?rid=2462354&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk8n7813857n2nu63%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The assessment of bone in children is more difficult than in adults mainly due to the effect of growth and/or puberty. Despite
 this, there is an increasing body of evidence showing that measurement of different components of bone is of clinical relevance.
 Fracture incidence peaks during the early teenage years, and dual energy X-ray absorptiometry (DXA) has been shown to predict
 fractures in children, especially those of the upper limb, in four prospective studies. Case control and cross-sectional studies
 have also shown similar associations for peripheral quantitative computed tomography (pQCT), heel ultrasound, metacarpal index,
 and skeletal age deviation. In some cases, these latter results are additive to DXA suggesting a multifaceted approach to
 bone assessme...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2462354</comments>
            <pubDate>Thu, 04 Jun 2009 11:08:43 +0100</pubDate>
            <guid isPermaLink="false">2462354</guid>        </item>
        <item>
            <title>Glucocorticoid-Induced Osteoporosis: A Review</title>
            <link>http://www.medworm.com/index.php?rid=2454356&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fmnvk4705841pt507%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Glucocorticoid (GC)-induced osteoporosis is the main cause of secondary osteoporosis. Fractures, which are often asymptomatic,
 can occur in as many as 50% of patients receiving chronic GC therapy. GCs have direct and indirect effects on bone cells (osteoblasts,
 osteocytes, and osteoclasts) with a suppression of bone formation and an increased bone resorption. The management of patients
 exposed to GCs should include the use of the minimal effective dose of GC, general health measures, and adequate intakes of
 calcium and vitamin D. Bisphosphonates are nowadays largely used in GC-induced osteoporosis and teriparatide has proved its
 efficiency as well.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12018-009-9051-9Authors
		Béatrice Bouvard, INSERM...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2454356</comments>
            <pubDate>Tue, 02 Jun 2009 08:15:14 +0100</pubDate>
            <guid isPermaLink="false">2454356</guid>        </item>
        <item>
            <title>Body Fat as a Regulator of Bone Mass: Experimental Evidence from Animal Models</title>
            <link>http://www.medworm.com/index.php?rid=2445590&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr7hk58546k7568u3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Animal models have proven valuable for elucidating the effects of body fat on bone metabolism, and this review highlights
 recent findings relevant for better understanding the relationship between adiposity and bone mass. Genetically obese mice
 and rats with altered leptin signaling consistently show reduced bone mass, demonstrating that leptin deficiency can contribute
 directly to osteopenia; however, the effect of leptin on bone is concentration dependent, such that relatively low doses of
 leptin stimulate bone formation, whereas high concentrations of leptin suppress bone formation and increase bone resorption.
 The hyperleptinemia associated with obesity and leptin receptor downregulation is therefore likely to have a negative impact
 on bone modeling and adapta...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2445590</comments>
            <pubDate>Thu, 28 May 2009 09:26:09 +0100</pubDate>
            <guid isPermaLink="false">2445590</guid>        </item>
        <item>
            <title>Adipose Tissue and Bone</title>
            <link>http://www.medworm.com/index.php?rid=2445589&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2q74163258kl4051%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;There is extensive clinical evidence that fat mass and bone mass are related to one another, and there are many laboratory
 and animal studies that explore the mechanisms of these relationships. However, there are a number of methodological issues
 that complicate the interpretation of both types of studies, and these need to be borne in mind as the studies reviewed in
 this volume are considered. These issues are reviewed in this introduction.
 
	Content Type Journal ArticleCategory IntroductionDOI 10.1007/s12018-009-9045-7Authors
		Ian R. Reid, University of Auckland Faculty of Medical and Health Sciences Private Bag 92019 Auckland New Zealand
	

	
		Journal Clinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644 (Source: Clinical Revi...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2445589</comments>
            <pubDate>Thu, 28 May 2009 09:26:09 +0100</pubDate>
            <guid isPermaLink="false">2445589</guid>        </item>
        <item>
            <title>Fatty Acids and Bone</title>
            <link>http://www.medworm.com/index.php?rid=2435737&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx7v0x24235085808%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Nutritional status is an important determinant of skeletal health. Increased fat mass favorably influences bone mineral density
 and reduces fracture risk. The mechanisms by which adiposity influences skeletal health include mechanical skeletal loading,
 the effects of adipocyte and pancreatic β-cell-derived hormones that act on bone, and neuroendocrine outputs from the hypothalamus
 that respond to peripheral nutritional signals. A growing body of evidence, including the recognition that specific fatty
 acid receptors are expressed in skeletal tissue, also suggests that fatty acids affect skeletal health. These effects include
 indirect actions of dietary and circulating fatty acids, mediated by hormonal signals derived from the intestine and pancreas,
 and direct eff...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2435737</comments>
            <pubDate>Sun, 24 May 2009 06:00:03 +0100</pubDate>
            <guid isPermaLink="false">2435737</guid>        </item>
        <item>
            <title>Marrow Fat and Bone: New Insights from Mice and Humans</title>
            <link>http://www.medworm.com/index.php?rid=2435738&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn2klx1014824nu42%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Adipocytes are an essential component of the bone marrow micro-environment. Developmentally, fatty infiltration of the marrow
 in the appendicular skeleton occurs at the time of peak bone acquisition. Conversely, vertebral marrow fat is most predominant
 with advancing age. Recent studies suggest that the amount of marrow fat is inversely associated with bone mineral density.
 It may also be a predictor of subsequent fracture. The molecular cellular and genetic aspects of marrow fat in mouse models
 and humans are discussed. More studies are needed to understand the relationship of marrow fat to mineral metabolism, energy
 balance, and skeletal fragility.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12018-009-9050-xAuthors
		Masanobu Kawai, Maine M...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2435738</comments>
            <pubDate>Sun, 24 May 2009 06:00:02 +0100</pubDate>
            <guid isPermaLink="false">2435738</guid>        </item>
        <item>
            <title>Adipokine Effects on Bone</title>
            <link>http://www.medworm.com/index.php?rid=2431409&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm422455l2u801726%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The adipocyte is an important source of factors that act as circulating regulators of bone metabolism. These include estrogens,
 and the adipokines, leptin, resistin, adiponectin, and probably others. Leptin acts directly on bone cells, and in some experimental
 models these effects are modified by its actions on the central nervous system, which impact on appetite, body weight, and
 insulin sensitivity. While not strictly an adipokine, insulin circulates in increased concentrations in obesity and exerts
 anabolic effects on bone. Adipokine levels correlate with bone turnover, suggesting that they dynamically influence bone metabolism.
 In postmenopausal women, they may be among the principal regulators of bone turnover, accounting for their increasing importance
 as de...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2431409</comments>
            <pubDate>Thu, 21 May 2009 06:01:15 +0100</pubDate>
            <guid isPermaLink="false">2431409</guid>        </item>
        <item>
            <title>Use of Bone Turnover Markers in Osteoporosis</title>
            <link>http://www.medworm.com/index.php?rid=2421703&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fvk2k2822h1648813%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Bone metabolism can be assessed by measuring bone turnover markers in serum or urine. Bone turnover markers are substances
 released from bone during bone turnover. They can be skeletal tissue proteins, collagen fragments, peptides, or enzymes released
 from bone cells. Bone turnover markers are extensively used in research applications but also as tools for the management
 of skeletal disorders in clinical practice. Osteoporosis-related applications may include assessment of response to, or deciding
 on osteoporosis therapy; identification of individuals with increased bone loss, and prediction of risk for fragility fractures.
 Advancements in the development of assays to measure bone markers has made the measurements available also for clinical practice.
 The possibil...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2421703</comments>
            <pubDate>Tue, 12 May 2009 05:51:05 +0100</pubDate>
            <guid isPermaLink="false">2421703</guid>        </item>
        <item>
            <title>Introduction</title>
            <link>http://www.medworm.com/index.php?rid=2395626&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq0170r1212290135%2F</link>
            <description>Content Type Journal ArticleCategory IntroductionDOI 10.1007/s12018-009-9043-9Authors
		Michael F. Holick, Boston University Medical Center Department of Medicine, Section of Endocrinology, Nutrition, and Diabetes, Vitamin D, Skin and Bone Research Laboratory Boston MA USA
	

	
		Journal Clinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644
	
		Journal Volume Volume 7
	
		Journal Issue Volume 7, Number 2 / June, 2009 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2395626</comments>
            <pubDate>Sat, 02 May 2009 05:48:39 +0100</pubDate>
            <guid isPermaLink="false">2395626</guid>        </item>
        <item>
            <title>Introduction</title>
            <link>http://www.medworm.com/index.php?rid=2395627&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp1422562l881k38r%2F</link>
            <description>Content Type Journal ArticleCategory IntroductionDOI 10.1007/s12018-009-9044-8Authors
		Michael F. Holick, Boston University Medical Center Vitamin D, Skin and Bone Research Laboratory, Section of Endocrinology, Nutrition, and Diabetes, Department of Medicine Boston MA USA
	

	
		Journal Clinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644
	
		Journal Volume Volume 7
	
		Journal Issue Volume 7, Number 1 / March, 2009 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2395627</comments>
            <pubDate>Sat, 02 May 2009 05:48:37 +0100</pubDate>
            <guid isPermaLink="false">2395627</guid>        </item>
        <item>
            <title>Vitamin D Deficiency and Its Health Consequences in Africa</title>
            <link>http://www.medworm.com/index.php?rid=2379446&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp5768n02jp95h136%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Africa is heterogeneous in latitude, geography, climate, food availability, religious and cultural practices, and skin pigmentation.
 It is expected, therefore, that prevalence of vitamin D deficiency varies widely, in line with influences on skin exposure
 to UVB sunshine. Furthermore, low calcium intakes and heavy burden of infectious disease common in many countries may increase
 vitamin D utilization and turnover. Studies of plasma 25OHD concentration indicate a spectrum from clinical deficiency to
 values at the high end of the physiological range; however, data are limited. Representative studies of status in different
 countries, using comparable analytical techniques, and of relationships between vitamin D status and risk of infectious and
 chronic diseases rele...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2379446</comments>
            <pubDate>Tue, 28 Apr 2009 12:57:48 +0100</pubDate>
            <guid isPermaLink="false">2379446</guid>        </item>
        <item>
            <title>Health Disparities and Vitamin D</title>
            <link>http://www.medworm.com/index.php?rid=2358467&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn31377266611243h%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Research over the last two to three decades has slowly demonstrated that Vitamin D, a long neglected and unappreciated hormone,
 is of profound importance to human health and survival. Vitamin D begins its synthesis in human skin with ultraviolet B radiation
 (UVB) from the sun. Melanin is a potent UVB blocker, protecting the skin from the high intensity sunlight found on the tropical
 savannah into which humans evolved, but not impairing the skin’s ability to synthesize generous quantities of vitamin D there.
 Adaptation to environmental availability of UVB radiation from the sun appears to explain the variation in skin melanin content
 in indigenous human populations around the world. Evidence shows populations in the United States have mean vitamin D levels
 that a...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2358467</comments>
            <pubDate>Tue, 21 Apr 2009 10:49:11 +0100</pubDate>
            <guid isPermaLink="false">2358467</guid>        </item>
        <item>
            <title>Vitamin D in Fracture Prevention and Muscle Function and Fall Prevention</title>
            <link>http://www.medworm.com/index.php?rid=2358498&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd068026018882524%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;This chapter reviews the potential of vitamin D for the prevention of falls and fractures. Evidence from randomized-controlled
 trials will be reviewed for both endpoints, as well as epidemiologic data that links higher 25-hydroxyvitamin D (25(OH)D)
 status to better bone and muscle health. The chapter addresses the evidence of fracture and fall prevention by dose of vitamin
 D, by type of dwelling and treatment duration. All data considered, this chapter summarizes the compelling dual benefit of
 vitamin D on fracture reduction by its bone and muscle target, a concept that is reviewed at the onset of the chapter.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12018-009-9037-7Authors
		Heike Bischoff-Ferrari, University of Zurich Department of Rheuma...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2358498</comments>
            <pubDate>Tue, 21 Apr 2009 10:49:09 +0100</pubDate>
            <guid isPermaLink="false">2358498</guid>        </item>
        <item>
            <title>Vitamin D and Health: Evolution, Biologic Functions, and Recommended Dietary Intakes for Vitamin D</title>
            <link>http://www.medworm.com/index.php?rid=2358483&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm58n3r3l125w5ul0%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Vitamin D deficiency is now being recognized as one of the most common medical conditions worldwide. The consequences of vitamin
 D deficiency include poor bone development and health as well as increased risk of many chronic diseases including type I
 diabetes; rheumatoid arthritis; Crohn’s disease; multiple sclerosis; heart disease; stroke; infectious diseases; as well as
 increased risk of dying of many deadly cancers including colon, prostate, and breast. The major source of vitamin D for most
 humans is exposure to sunlight. However, avoidance of sun exposure has resulted in an epidemic of vitamin D deficiency. Once
 vitamin D is made in the skin or ingested from the diet, it requires activation steps in the liver and kidney to form 25-hydroxyvitamin
 D [25(OH)D]...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2358483</comments>
            <pubDate>Tue, 21 Apr 2009 10:49:09 +0100</pubDate>
            <guid isPermaLink="false">2358483</guid>        </item>
        <item>
            <title>Vitamin D Deficiency in the Middle East and its Health Consequences for Children and Adults</title>
            <link>http://www.medworm.com/index.php?rid=2358512&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F507l5v608428n61x%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Despite its abundant sunshine the Middle East, a region spanning latitudes from 12°N to 42°N allowing vitamin D synthesis
 year round, registers some of the lowest levels of vitamin D and the highest rates of hypovitaminosis D worldwide. This major
 public health problem affects individuals across all life stages including pregnant women, neonates, infants, children and
 adolescents, adults, and the elderly. Furthermore, while rickets is almost eradicated from developed countries, it is still
 reported in several countries in the Middle East. These observations can be explained by limited sun exposure due to cultural
 practices, dark skin color, and very hot climate in several countries in the gulf area, along with prolonged breast feeding
 without vitamin D supplemen...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2358512</comments>
            <pubDate>Tue, 21 Apr 2009 10:49:08 +0100</pubDate>
            <guid isPermaLink="false">2358512</guid>        </item>
        <item>
            <title>The Health Benefits of Solar Irradiance and Vitamin D and the Consequences of Their Deprivation</title>
            <link>http://www.medworm.com/index.php?rid=2320367&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff2455802t4766021%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Originally recognized for reducing the risk of rickets, the benefits of vitamin D were extended in the past three decades,
 to protection against many non-calcemic diseases. The primary source of vitamin D is production by solar ultraviolet B (UVB)
 irradiance. In this paper, evidence is reviewed that vitamin D reduces the risk of about 17 types of cancer; bacterial infections
 for diseases such as dental caries, periodontitis, septicemia, and tuberculosis; viral infections such as respiratory infections
 and Epstein-Barr virus; autoimmune diseases such as asthma and multiple sclerosis; cardiovascular diseases such as coronary
 heart disease, diabetes, and stroke; and dementia. Several studies have also reported longer life expectancy with higher vitamin
 D supplement o...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2320367</comments>
            <pubDate>Wed, 01 Apr 2009 06:03:44 +0100</pubDate>
            <guid isPermaLink="false">2320367</guid>        </item>
        <item>
            <title>The Functional Metabolism and Molecular Biology of Vitamin D Action</title>
            <link>http://www.medworm.com/index.php?rid=2320366&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp88803123p4t77m3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The evolution of our understanding of the biological impact of vitamin D is briefly reviewed, with a focus on the physiology
 and endocrinology of the vitamin D system. This chapter attempts to bring the molecular discoveries in vitamin D metabolism
 and mechanisms of action into focus on known physiology and endocrinology. The latest developments on metabolism of vitamin
 D, the enzymes involved, and the genes responsible are presented. The impact of the molecular discoveries on current views
 of the importance of vitamin D in public health is also presented.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12018-009-9040-zAuthors
		Lori A. Plum, University of Wisconsin-Madison Department of Biochemistry 433 Babcock Drive Madison WI 53706 USAHector F....</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2320366</comments>
            <pubDate>Wed, 01 Apr 2009 06:03:44 +0100</pubDate>
            <guid isPermaLink="false">2320366</guid>        </item>
        <item>
            <title>Vitamin D for Cancer Prevention and Survival</title>
            <link>http://www.medworm.com/index.php?rid=2320368&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fbl1788224m55311n%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Higher levels of the principal circulating form of vitamin D, 25-hydroxyvitamin D (25(OH)D), are associated with substantially
 lower incidence and death rates from colon, breast, and ovarian cancer, with a linear dose–response gradient. The accumulated
 evidence from observational studies and a randomized trial reveal that population serum levels of 25(OH)D in the range of
 40 to 50&amp;nbsp;ng/ml will markedly reduce incidence and mortality rates of several cancers including those of the breast, colon,
 and ovary. There is an immediate clinical need for cancer care providers worldwide to assure that a serum 25(OH)D level &amp;gt;40&amp;nbsp;ng/ml
 is achieved as soon as feasible after diagnosis of patients with breast and colon cancer, unless specifically contraindicated
 by pr...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2320368</comments>
            <pubDate>Tue, 31 Mar 2009 05:59:11 +0100</pubDate>
            <guid isPermaLink="false">2320368</guid>        </item>
        <item>
            <title>Vitamin D and Type 2 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=2320369&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj718466236877l88%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Vitamin D has been reported to have a variety of non-skeletal actions, including on glucose metabolism. There has been increasing
 evidence from animal and human studies, to suggest that vitamin D may be important in modifying risk of type 2 diabetes. Vitamin
 D is thought to have both direct (through activation of the vitamin D receptor) and indirect (via regulation of calcium homeostasis)
 effects on various mechanisms related to the pathophysiology of type 2 diabetes, including pancreatic beta-cell dysfunction,
 impaired insulin action, and systemic inflammation. The evidence from human studies comes primarily from cross-sectional and
 a few prospective observational studies showing an inverse association between vitamin D status and prevalence or incidence
 of type ...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2320369</comments>
            <pubDate>Fri, 27 Mar 2009 07:01:35 +0100</pubDate>
            <guid isPermaLink="false">2320369</guid>        </item>
        <item>
            <title>25-Hydroxyvitamin D-1α Hydroxylase: Studies in Mouse Models and Implications for Human Disease</title>
            <link>http://www.medworm.com/index.php?rid=2293576&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6w574754x3276156%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Genetic mouse models with targeted deletion (“knockout”) of the 25-hydroxyvitamin D-1alpha-hydroxylase gene [1α(OH)ase−/−], as well as with targeted deletion of the VDR gene, when exposed to different dietary regimens, have provided considerable
 insight into the molecular regulation of skeletal physiology by the 1,25(OH)2D/VDR system. These regimens induced different phenotypic changes and demonstrated that parathyroid gland size and the development
 of the cartilaginous growth plate were each co-ordinately regulated by calcium and by 1,25(OH)2D, and that parathyroid hormone (PTH) secretion and mineralization of bone reflected ambient calcium (and phosphorus) levels
 rather than the direct actions of the 1,25(OH)2D/VDR system. In contrast, increased calcium ab...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2293576</comments>
            <pubDate>Sat, 21 Mar 2009 08:49:22 +0100</pubDate>
            <guid isPermaLink="false">2293576</guid>        </item>
        <item>
            <title>Vitamin D and Innate Immunity</title>
            <link>http://www.medworm.com/index.php?rid=2293579&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm2p8j17ql0164271%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;This chapter will examine the role of vitamin D in the innate immune system as a mediator of human host defense mechanisms
 microbial disease, focusing on tuberculosis. The first section will examine tuberculosis and the innate immune response to
 the intracellular pathogen, Mycobacterium tuberculosis (M.
 tuberculosis), the causative agent of tuberculosis. This is followed by a discussion of the known associations, genetic and mechanistic,
 between the vitamin D pathway and tuberculosis susceptibility. Finally, the chapter will conclude with a discussion on the
 potential for adjuvant treatment of tuberculosis with vitamin D.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12018-009-9034-xAuthors
		Philip Liu, UCLA Orthopaedic Hospital Research Cente...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2293579</comments>
            <pubDate>Sat, 21 Mar 2009 08:49:21 +0100</pubDate>
            <guid isPermaLink="false">2293579</guid>        </item>
        <item>
            <title>Vitamin D Deficiency in Children and Its Health Consequences</title>
            <link>http://www.medworm.com/index.php?rid=2293582&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd771065703333580%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;This chapter reviews data on the prevalence of vitamin D deficiency, risk factors that predispose children and adolescents
 to this problem, and current approaches to routine vitamin D supplementation and treatment of vitamin D deficiency. The increasing
 world-wide prevalence of vitamin D deficiency among otherwise healthy pediatric patients is explored. Risk factors for vitamin
 D deficiency have been identified and include, among others, northern geographical location, dark skin pigmentation, female
 gender, lack of supplementation, and diseases associated with malabsorption. While supplementation strategies to prevent vitamin
 D deficiency have not been standardized for infants, children, and adolescents, previous studies comparing different doses
 have been tested ...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2293582</comments>
            <pubDate>Sat, 21 Mar 2009 08:49:20 +0100</pubDate>
            <guid isPermaLink="false">2293582</guid>        </item>
        <item>
            <title>Vitamin D and the Brain: A Neuropsychiatric Perspective</title>
            <link>http://www.medworm.com/index.php?rid=2293585&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv061623n7rv11844%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Based on clues from epidemiology, it has been proposed that low prenatal vitamin D may be a risk factor for schizophrenia.
 In order to explore this hypothesis, our group has undertaken an integrated research program linking analytic epidemiology
 and rodent experiments. There is consistent evidence from rodents that offspring exposed to low developmental vitamin D deficiency
 have altered brain structure and function as adults. This chapter provides a concise summary of the evidence linking vitamin
 D to brain development and function. In addition, the epidemiological evidence linking hypovitaminosis D and various neuropsychiatric
 disorders is outlined.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12018-009-9031-0Authors
		Louise Harvey, Queensla...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2293585</comments>
            <pubDate>Sat, 21 Mar 2009 08:49:18 +0100</pubDate>
            <guid isPermaLink="false">2293585</guid>        </item>
        <item>
            <title>The Epidemiology of Vitamin D and Cancer Risk</title>
            <link>http://www.medworm.com/index.php?rid=2293588&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc849742316723658%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The relation between vitamin D status and cancer risk has been investigated in a number of epidemiologic studies, while data
 from interventional studies remain scarce. The approaches to estimate vitamin D status have been varied, and include direct
 measures of circulating 25(OH)vitamin D (25(OH)D) levels, surrogates, or determinants of 25(OH)D, including region of residence,
 intake, and sun exposure estimates. In terms of cancer sites, the body of evidence is the most extensive for colorectal cancer,
 for which support comes from studies of 25(OH)D, vitamin D intake, multiple predictors of 25(OH)D, and region of residence
 in a sunny climate. The evidence for breast cancer is also intriguing, but prospective studies of 25(OH)D are sparse and somewhat
 conflicting. In...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2293588</comments>
            <pubDate>Sat, 21 Mar 2009 08:49:15 +0100</pubDate>
            <guid isPermaLink="false">2293588</guid>        </item>
        <item>
            <title>Extra Renal Synthesis of 1,25-dihydroxyvitamin D and its Health Implications</title>
            <link>http://www.medworm.com/index.php?rid=2281481&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fgr9t0433457pxg89%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Although the kidney was initially thought to be the sole organ responsible for the production of 1,25(OH)2D3 via its enzyme CYP27b1, it is now appreciated that the expression of CYP27b1 in tissues other than the kidney is wide spread.
 However, the kidney is the major source for circulating 1,25(OH)2D3. Therefore the existence of the capacity for extra renal 1,25(OH)2D3 production begs the question why, and in particular whether the extra renal production of 1,25(OH)2D3 has physiologic importance. In this chapter this question will be discussed. First a compilation of the extra renal sites
 for CYP27b1 expression is provided. This is followed by a discussion of the regulation of CYP27b1 expression and activity
 in extra renal tissues, pointing out that such regulation i...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2281481</comments>
            <pubDate>Wed, 18 Mar 2009 07:00:10 +0100</pubDate>
            <guid isPermaLink="false">2281481</guid>        </item>
        <item>
            <title>Vitamin D Deficiency in Pregnancy and Lactation and Health Consequences</title>
            <link>http://www.medworm.com/index.php?rid=2281480&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fqv604w6t2340r646%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Pregnancy and lactation represent time periods where health status affects two persons instead of one. With the monumental
 development and growth that occurs in fetal and in early life, optimizing health status is imperative. An important part of
 health status is achieving and sustaining vitamin D sufficiency with vitamin D’s critical function in bone health, immune
 function, and cell proliferation. Investigation regarding the short-term and long-term effect of vitamin D status during these
 times is exponentially growing and, so far, demonstrates important roles for vitamin D in both maternal and infant bone health,
 glucose tolerance, and immune function. In addition, evidence points to a critical role for vitamin D in sustaining pregnancy
 and avoiding pregnancy...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2281480</comments>
            <pubDate>Wed, 18 Mar 2009 07:00:10 +0100</pubDate>
            <guid isPermaLink="false">2281480</guid>        </item>
        <item>
            <title>Affective Disorders, Bone Metabolism, and Osteoporosis</title>
            <link>http://www.medworm.com/index.php?rid=2222956&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy58t322731nlw102%2F</link>
            <description>The objective of this review is to describe the current
 evidence regarding the association of unipolar and bipolar depression with BMD and indicators of bone metabolism, and to explore
 potential mediating and confounding influences of those relationships. The majority of studies of unipolar depression and
 BMD indicate that depressive symptoms are associated with low BMD. In contrast, evidence regarding the relationship between
 bipolar depression and BMD is inconsistent. There is limited but suggestive evidence to support an association between affective
 disorders and some markers of bone turnover. Many medications used to treat affective disorders have effects on physiologic
 systems that influence bone metabolism, and these conditions are also associated with a range of health behavi...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2222956</comments>
            <pubDate>Wed, 25 Feb 2009 10:25:54 +0100</pubDate>
            <guid isPermaLink="false">2222956</guid>        </item>
        <item>
            <title>TSH and Thyroid Hormones Both Regulate Bone Mass</title>
            <link>http://www.medworm.com/index.php?rid=2163802&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk5x6817855g92111%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Thyrotoxicosis is associated with a high-turnover osteoporosis, which has been solely attributed to elevated thyroid hormone
 levels. Mice lacking the thyroid hormone receptors α and β establish a role for thyroid hormones in regulating bone remodeling.
 We show that TSH, which falls when thyroid hormones rise, directly suppresses bone remodeling, and that TSH receptor null
 mice have profound bone loss. We suggest that reduced TSH signaling contributes to hyperthyroid osteoporosis and that TSH
 and its receptor could become valuable drug targets.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12018-009-9024-zAuthors
		Li Sun, Mount Sinai School of Medicine The Mount Sinai Bone Program One Gustave L. Levy Place New York 10029 NY USAXuan Liu, Mount ...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2163802</comments>
            <pubDate>Wed, 04 Feb 2009 14:01:03 +0100</pubDate>
            <guid isPermaLink="false">2163802</guid>        </item>
        <item>
            <title>Bone Disease and Idiopathic Hypercalciuria</title>
            <link>http://www.medworm.com/index.php?rid=1921178&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F003kp1327121u857%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;There is sufficient epidemiological and clinical data demonstrating an association between reduced bone mineral density and
 idiopathic hypercalciuria (IH). There have been relatively few studies that have addressed the underlying defect in bone remodeling.
 The limited studies to date suggest that increased bone turnover occurs in some forms of IH such as fasting hypercalciuria
 or renal calcium leak and explains the bone loss observed in these forms of IH. On the other hand, defective bone formation
 is the major defect observed in patients with IH resulting from intestinal hyperabsorption of calcium. These alterations in
 bone remodeling have been ascribed to genetic, metabolic, and nutritional causes. Although there are several therapeutic options
 available for tre...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1921178</comments>
            <pubDate>Wed, 29 Oct 2008 06:50:03 +0100</pubDate>
            <guid isPermaLink="false">1921178</guid>        </item>
        <item>
            <title>Osteopetrosis: from Animal Models to Human Conditions</title>
            <link>http://www.medworm.com/index.php?rid=1790465&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx4473xr4174064t3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The term “osteopetrosis” is applied to a group of disorders characterized by an increased bone density, due to an inadequate
 bone resorption. A considerable part of our current knowledge on osteoclast biology is based on the study of osteopetrotic
 animal models. The search for mutations in these animals has unveiled many molecular mechanisms underlying osteoclast differentiation
 and functioning. It also supplied new candidate genes for the identification of genes involved in the human variants of this
 disease. All osteopetrotic genes identified so far in humans have their animal counterpart. The reverse is not true. This
 can partially be explained by the fact that still more than 30% of all patients suffer from osteopetrosis with an unkown molecular
 defect. Th...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1790465</comments>
            <pubDate>Fri, 12 Sep 2008 08:10:37 +0100</pubDate>
            <guid isPermaLink="false">1790465</guid>        </item>
        <item>
            <title>Surface-specific Bone Formation Effects of Osteoporosis Pharmacological Treatments</title>
            <link>http://www.medworm.com/index.php?rid=1729623&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F172l5043pp475456%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Current anti-osteoporotic pharmacological treatments reduce fracture risk in part by altering bone remodeling/modeling. These
 effects can manifest on any or all of the bone envelopes—periosteal, intracortical, and trabecular/endocortical—each of which
 has unique effects on the biomechanical properties of bone. The purpose of this review is to provide an overview of how the
 most common FDA-approved anti-osteoporosis agents [bisphosphonates, estrogen/hormone replacement therapy, selective estrogen
 receptor modulators (SERMs), and parathyroid hormone (PTH)] affect tissue-level remodeling/modeling on each of the bone surfaces.
 Iliac crest biopsy data, the only means of assessing surface-specific bone formation in humans, exist for all of these agents
 although they...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1729623</comments>
            <pubDate>Fri, 22 Aug 2008 12:46:34 +0100</pubDate>
            <guid isPermaLink="false">1729623</guid>        </item>
        <item>
            <title>Introduction</title>
            <link>http://www.medworm.com/index.php?rid=1723598&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg6r1q483l30r3681%2F</link>
            <description>Content Type Journal ArticleCategory IntroductionDOI 10.1007/s12018-008-9020-8Authors
		Daniel D. Bikle, University of California Department of Medicine and Dermatology, Veterans Affairs Medical Center San Francisco CA 94121 USA
	

	
		Journal Clinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1723598</comments>
            <pubDate>Tue, 19 Aug 2008 23:05:32 +0100</pubDate>
            <guid isPermaLink="false">1723598</guid>        </item>
        <item>
            <title>Adaptation of the Skeletal System During Long-Duration Spaceflight</title>
            <link>http://www.medworm.com/index.php?rid=1660967&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3783j634465474w4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;This review will highlight evidence from crew members flown on space missions &amp;gt;90&amp;nbsp;days to suggest that the adaptations of
 the skeletal system to mechanical unloading may predispose crew members to an accelerated onset of osteoporosis after return
 to Earth. By definition, osteoporosis is a skeletal disorder—characterized by low bone mineral density (BMD) and structural
 deterioration—that reduces the ability of bones to resist fracture under the loading of normal daily activities. “Involutional”
 or age-related osteoporosis is readily recognized as a syndrome afflicting the elderly population because of the insipid and
 asymptomatic nature of bone loss that does not typically manifest as fractures until after age ∼60. It is not the thesis of
 this rev...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1660967</comments>
            <pubDate>Sat, 26 Jul 2008 08:56:54 +0100</pubDate>
            <guid isPermaLink="false">1660967</guid>        </item>
        <item>
            <title>Nongenomic Actions of Thyroid Hormone and Intracellular Calcium Metabolism</title>
            <link>http://www.medworm.com/index.php?rid=1657306&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6161643j56tt7365%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Nongenomic actions of thyroid hormone include several that involve or require calcium. Actions of thyroid hormone at the plasma
 or intracellular membranes include stimulation of membrane glucose transport and of the Na+/H+ antiporter (exchanger) by mechanisms that require liberation of intracellular calcium and stimulation of the cell membrane
 and sarcoplasmic reticulum calcium pumps (Ca2+-ATPases). These pumps not only transport Ca2+, but also are regulated by the intracellular calmodulin-Ca2+ complex (plasma membrane/sarcolemma) or calmodulin-dependent protein kinase II phosphorylation of phospholamban (sarcoplasmic
 reticulum). Intracellular calcium ion concentration may also be subject to regulation by other nongenomic effects of iodothyronines,
 such as those on ...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1657306</comments>
            <pubDate>Fri, 25 Jul 2008 16:23:48 +0100</pubDate>
            <guid isPermaLink="false">1657306</guid>        </item>
        <item>
            <title>Alterations in Bone Mineral Density in Marfan Syndrome and Homocystinuria</title>
            <link>http://www.medworm.com/index.php?rid=1616372&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff6523525w8360245%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Homocystinuria and Marfan syndrome represent distinct genetic conditions that share phenotypically similar skeletal features.
 An overview of the current understanding of genetic and physiologic contributing to the etiology of these conditions is summarized.
 The focus of this review is to explore the present understanding of the pathophysiology of Marfan syndrome and homocystinuria
 relative to the occurrence of osteoporosis in both conditions. Osteoporosis has been reported in association with homocystinuria.
 However, evidence supporting an association of osteoporosis with Marfan syndrome is equivocal and sources of ambiguity are
 critically reviewed. Advisability and approaches to bone mineral density monitoring in patients with Marfan syndrome or homocystinuria
 to...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1616372</comments>
            <pubDate>Fri, 11 Jul 2008 07:09:38 +0100</pubDate>
            <guid isPermaLink="false">1616372</guid>        </item>
        <item>
            <title>Combination Therapy Using Exercise and Pharmaceutical Agents to Optimize Bone Health</title>
            <link>http://www.medworm.com/index.php?rid=1522384&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F90v8v719n02r6h7w%2F</link>
            <description>This article discusses the tissue-level processes
 regulating bone health, mechanisms of action of exercise and pharmaceutical agents, and rationale and current evidence for
 combined exercise and pharmaceutical intervention for optimizing bone health.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12018-008-9017-3Authors
		R. K. Fuchs, Indiana University Department of Physical Therapy, School of Health and Rehabilitation Sciences 1140 West Michigan Street, CF-326 Indianapolis IN 46202 USAS. J. Warden, Indiana University Department of Physical Therapy, School of Health and Rehabilitation Sciences 1140 West Michigan Street, CF-326 Indianapolis IN 46202 USA
	

	
		Journal Clinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644 (Source: Cli...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1522384</comments>
            <pubDate>Sat, 14 Jun 2008 05:58:44 +0100</pubDate>
            <guid isPermaLink="false">1522384</guid>        </item>
        <item>
            <title>Role of the Klotho Gene in Bone and Mineral Metabolism</title>
            <link>http://www.medworm.com/index.php?rid=1497665&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl36h3r832l674334%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Klotho was originally identified when a random insertional mutation disrupting the mouse gene caused an abnormal phenotype
 with accelerated aging and shortened lifespan. Klotho appears to play an important role in the renal handling of calcium and
 phosphate, in part by interacting with the FGF23 signaling system. In general, klotho tends to decrease phosphate retention
 and 1,25-dihydroxyvitamin D3 synthesis. It directly stimulates calcium reabsorption in the kidney and tends to increases serum
 calcium, but may have opposite indirect effects related to the changes in vitamin D metabolism. Klotho may also influence
 the response of the parathyroids to hypocalcemia and may interact with other biological systems, including Wnt, OPG/RANKL,
 insulin/IGF-I, and sex steroid...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1497665</comments>
            <pubDate>Wed, 04 Jun 2008 07:28:42 +0100</pubDate>
            <guid isPermaLink="false">1497665</guid>        </item>
        <item>
            <title>Extracellular Matrix and Integrin Interactions in the Skeletal Responses to Mechanical Loading and Unloading</title>
            <link>http://www.medworm.com/index.php?rid=1482168&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb441246r7175vk82%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The adaptation of the skeleton to changes in mechanical loading depends on the ability of bone cells first to detect then
 to convert diverse mechanical forces into chemical signals that regulate cell behavior, a process known as mechanotransduction.
 A network of interactions between the extracellular matrix, integrin receptors that span the cell membrane, and intracellular
 cytoskeletal and signaling elements participates in mechanotransduction along with other proteins, most notably ion channels.
 Integrins are a family of heterodimeric proteins with binding specificity for extracellular matrix proteins, and the ability
 to influence cell behavior via various key effector functions in addition to mechanotransduction, including adhesion, motility,
 differentiation, pr...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1482168</comments>
            <pubDate>Fri, 30 May 2008 05:55:26 +0100</pubDate>
            <guid isPermaLink="false">1482168</guid>        </item>
        <item>
            <title>Estrogen Receptors Critically Regulate Bones’ Adaptive Responses to Loading</title>
            <link>http://www.medworm.com/index.php?rid=1482169&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3385466u27152300%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Estrogen receptors critically regulate a number of steps in the pathways in osteoblasts and osteocytes activated by exposure
 to dynamic mechanical strain. It is these pathways that are responsible for converting the immediate effects of strain change
 into a coherent stimulus for (re)modelling. It is this stimulus that controls the (re)modelling responsible for matching bones’
 architecture to their customary loading. Less effective processing of this strain-related stimulus will have the same downstream
 effects as the absence of strain. The (re)modelling consequences are the same as those of disuse; bone loss to a genetically
 determined minimum. Here we review studies showing involvement of the estrogen receptor in a number of bone cells’ early responses
 to mec...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1482169</comments>
            <pubDate>Fri, 30 May 2008 05:55:24 +0100</pubDate>
            <guid isPermaLink="false">1482169</guid>        </item>
        <item>
            <title>Skeletal Microdamage: Less About Biomechanics and More About Remodeling</title>
            <link>http://www.medworm.com/index.php?rid=1478167&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff1350jp883762396%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The mechanical consequences of skeletal microdamage have been clearly documented using various experimental methods, yet recent
 experiments suggest that physiological levels of microdamage accumulation are not sufficient to compromise the bones’ biomechanical
 properties. While great advances have been made in our understanding of the biomechanical implications of microdamage, less
 is known concerning the physiological role of microdamage in bone remodeling. Microdamage has been shown to act as a signal
 for bone remodeling, likely through a disruption of the osteocyte-canalicular network. Interestingly, age-related increases
 in microdamage are not accompanied by increases in bone remodeling suggesting that the physiological mechanisms which link
 microdamage and r...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1478167</comments>
            <pubDate>Wed, 28 May 2008 06:38:35 +0100</pubDate>
            <guid isPermaLink="false">1478167</guid>        </item>
        <item>
            <title>Integrin Regulation of the IGF-I Receptor in Bone, and the Response to Load</title>
            <link>http://www.medworm.com/index.php?rid=1450384&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy3375176k0800028%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Bone loss during skeletal unloading, whether due to neurotrauma resulting in paralysis or prolonged immobilization due to
 a variety of medical illnesses, accelerates bone loss. In this review the evidence that skeletal unloading leads to bone loss
 at least in part due to disrupted IGF signaling, resulting in reduced osteoblast proliferation and differentiation, will be
 examined. The mechanism underlying this disruption in IGF signaling appears to involve integrins, the expression of which
 is reduced during skeletal unloading. Integrins play an important, albeit not well defined, role in facilitating signaling
 not only by IGF but also by other growth factors. However, the interaction between selected integrins such as αVβ3 and β1
 and the IGF receptor are of espe...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1450384</comments>
            <pubDate>Fri, 16 May 2008 06:12:52 +0100</pubDate>
            <guid isPermaLink="false">1450384</guid>        </item>
        <item>
            <title>Skeletal Adaptation to Mechanical Loading</title>
            <link>http://www.medworm.com/index.php?rid=1443113&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh772618785rg534v%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Over the past 40&amp;nbsp;years, much has been learnt about how mechanical loading affects bone structure. The latest studies suggest
 that bone cells detect mechanical loads through integrin linkages at focal adhesions. Loading stimulates new bone formation,
 which is due in part to increased signaling through the Wnt/LRP5 pathway. Skeletal disuse both suppresses periosteal bone
 formation and increases bone resorption. The latter effect is due mostly to increased RANKL signaling that stimulates new
 osteoclasts. Increasing the rate or frequency by which loading is applied greatly improves bone tissue mechanosensitivity,
 possibly due to loading-induced extracellular fluid forces around osteocytes, which serve as mechanosensors. In addition,
 osteogenesis after mechanical ...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1443113</comments>
            <pubDate>Tue, 13 May 2008 06:09:23 +0100</pubDate>
            <guid isPermaLink="false">1443113</guid>        </item>
        <item>
            <title>Osteocytes: Mechanosensors of Bone and Orchestrators of Mechanical Adaptation</title>
            <link>http://www.medworm.com/index.php?rid=1443112&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr6k744h315233483%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Significant progress has been made in the field of mechanotransduction in bone cells. The knowledge about the role of osteocytes
 as the professional mechanosensor cells of bone as well as the lacuno-canalicular porosity as the structure that mediates
 mechanosensing is increasing. New insights might result in a paradigm for understanding the bone formation response to mechanical
 loading, and the bone resorption response to disuse. Under physiological loading conditions the strain-derived flow of interstitial
 fluid through the lacuno-canalicular porosity seems to mechanically activate the osteocytes, which subsequently alter the
 bone remodeling activity of osteoblasts and/or osteoclasts. Fatigue loading results in local microdamage, disruption of normal
 flow pattern...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1443112</comments>
            <pubDate>Tue, 13 May 2008 06:09:23 +0100</pubDate>
            <guid isPermaLink="false">1443112</guid>        </item>
        <item>
            <title>New Insights into the Roles of Fibroblast Growth Factor 23</title>
            <link>http://www.medworm.com/index.php?rid=1432740&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff6112g37033h23g1%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Fibroblast growth factor 23 (FGF23) is expressed primarily in skeletal tissues including osteoblasts/osteocytes and acts as
 a hormone regulating phosphate and vitamin D homeostasis. An excess of active FGF23 in the circulation causes multiple anomalies
 seen in phosphaturic diseases including rickets/osteomalacia, consistent with some but not all of the phenotypic anomalies
 seen in FGF23 deficient mice. FGF23 is targeted to kidney and negatively regulates activity/expression of the type II sodium-phosphate
 cotransporter (NPT2) as well as 25-hydroxy vitamin D-1α-hydroxylase in proximal tubular cells. Recently, teeth have been identified
 as a possible second principle source of FGF23. Further, both the parathyroid and bone also appear to be functional targets
 of FGF...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1432740</comments>
            <pubDate>Wed, 07 May 2008 14:53:07 +0100</pubDate>
            <guid isPermaLink="false">1432740</guid>        </item>
        <item>
            <title>Bisphosphonates for the Treatment of Postmenopausal Osteoporosis: An Update</title>
            <link>http://www.medworm.com/index.php?rid=1082152&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fgq10721k507177p7%2F</link>
            <description>This article reviews the results of recent studies on the efficacy and safety of bisphosphonates for the
 treatment of postmenopausal osteoporosis. Results of randomized trials using novel dosing regimens of bisphosphonates are
 discussed. Outcomes include bone mineral density, bone turnover markers fractures adverse events.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12018-007-9006-yAuthors
		Ann Cranney, University of Ottawa Department of Medicine, Ottawa Health Research Institute 1053 Carling Ave K1Y 4E9 Ottawa ON CanadaJonathan D. Adachi, St. Joseph’s Healthcare – McMaster University Department of Medicine Hamilton ON Canada
	

	
		Journal Clinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644 (Source: Clinical Reviews in Bon...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1082152</comments>
            <pubDate>Fri, 07 Dec 2007 16:37:47 +0100</pubDate>
            <guid isPermaLink="false">1082152</guid>        </item>
        <item>
            <title>Introduction</title>
            <link>http://www.medworm.com/index.php?rid=1057451&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff57l542k50r7q074%2F</link>
            <description>Content Type Journal ArticleCategory IntroductionDOI 10.1007/s12018-007-9007-xAuthors
		Jonathan D. Adachi, St. Joseph’s Healthcare-McMaster University Department of Medicine 25 Charlton Avenue East, Suite 501 Hamilton ON Canada L8N1Y2
	

	
		Journal Clinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1057451</comments>
            <pubDate>Tue, 27 Nov 2007 15:39:04 +0100</pubDate>
            <guid isPermaLink="false">1057451</guid>        </item>
        <item>
            <title>Related disorders of bone</title>
            <link>http://www.medworm.com/index.php?rid=991981&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn138478q37n460g3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Renal osteodystrophy includes a broad spectrum of abnormalities in bone and mineral metabolism. This review article discusses
 related bone disorders, including calcific uremic arteriolopathy, “osteoporosis” and compromised bone strength, and dialysis-related
 amyloidosis, as well as the contributing roles of glucocorticoids and metabolic acidosis. Bone disorders in the setting of
 renal transplantation, including osteoporosis, osteonecrosis, and presistent hyperparathyroidism, are also reviewed.
 
	Content Type Journal ArticleDOI 10.1007/BF02736670Authors
		Francis L. Weng, Saint Barnabas Medical Center Renal and Pancreas Transplant Division Livingston NJStanley Goldfarb, Saint Barnabas Medical Center Renal and Pancreas Transplant Division Livingston NJ
	

	
		Jour...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=991981</comments>
            <pubDate>Mon, 29 Oct 2007 14:36:13 +0100</pubDate>
            <guid isPermaLink="false">991981</guid>        </item>
        <item>
            <title>National Kidney Foundation K-DOQI: Clinical practice guidelines for bone metabolism and disease in chronic kidney disease</title>
            <link>http://www.medworm.com/index.php?rid=991980&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx7v64h68l467w688%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/BF02736671

	
		Journal Clinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644
	
		Journal Volume Volume 5
	
		Journal Issue Volume 5, Number 1 / December, 2007 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=991980</comments>
            <pubDate>Mon, 29 Oct 2007 14:36:13 +0100</pubDate>
            <guid isPermaLink="false">991980</guid>        </item>
        <item>
            <title>Diagnosis of renal osteodystrophy</title>
            <link>http://www.medworm.com/index.php?rid=991986&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe12413t00mh8p262%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Chronic Kidney Disease (CKD) is commonly associated with alterations in bone and mineral metabolism (renal osteodystrophy).
 To date, bone biopsy remains the gold standard for the diagnosis and classification of the various types of renal osteodystrophy,
 namely: osteitis fibrosa, mixed uremic osteodystrophy, osteomalacia, aplastic and adynamic bone disease. However, due to its
 invasive nature and the fact that it is quite expensive, there has been a clamor for a search for other tests. Traditionally,
 the level of parathyroid hormone (PTH) has been considered a surrogate of bone turnover. At this time, the search continues
 for a specific and sensitive biochemical marker for monitoring bone turnover in CKD., e.g., alkaline phosphatase, osteocalcin,
 collagen degradati...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=991986</comments>
            <pubDate>Mon, 29 Oct 2007 14:36:12 +0100</pubDate>
            <guid isPermaLink="false">991986</guid>        </item>
        <item>
            <title>Definition and classification of renal osteodystrophy</title>
            <link>http://www.medworm.com/index.php?rid=991985&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F637783080rn376tm%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;One of the major complications that arise as a result of chronic kidney disease is that of ‘renal osteodystrophy.’ It is believed
 to be a multifactorial disorder of altered bone modeling. Bone biopsy occupies a central role in the differentiation of the
 various kinds of renal osteodystrophy based on histological findings. However, due to its limitations of being a rather invasive
 and costly procedure, it is performed rather infrequently. Therefore, scientists started to focus on alternative measures
 of classifying the various types, e.g., the parathyroid hormone (PTH). PTH has been used as an indicator of bone turnover,
 thereby dividing the diseases into those of high turnover and low turnover. To further our understanding of this particular
 disease entity, a ...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=991985</comments>
            <pubDate>Mon, 29 Oct 2007 14:36:12 +0100</pubDate>
            <guid isPermaLink="false">991985</guid>        </item>
        <item>
            <title>Treatment of renal osteodystrophy</title>
            <link>http://www.medworm.com/index.php?rid=991984&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd0w6737071h22532%2F</link>
            <description>This article discusses
 the therapeutic approaches focuses for renal osteodystrophy.
 
	Content Type Journal ArticleDOI 10.1007/BF02736669Authors
		Anca Gal-Moscovici, Hebrew University Hadassah Hospital Medical Center Ein Keren, Jeruslaem IsraelStuart M. Sprague, Northwestern University Feinberg School of Medicine Division of Nephrology and Hypertension, Evanston Northwestern Healthcare Evanston ILEdgar V. Lerma, University of Illinois at Chicago College of Medicine/Associates in Nephrology Section of Nephrology Chicago IL
	

	
		Journal Clinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644
	
		Journal Volume Volume 5
	
		Journal Issue Volume 5, Number 1 / December, 2007 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=991984</comments>
            <pubDate>Mon, 29 Oct 2007 14:36:12 +0100</pubDate>
            <guid isPermaLink="false">991984</guid>        </item>
        <item>
            <title>Introduction</title>
            <link>http://www.medworm.com/index.php?rid=991983&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw141811003t86155%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/BF02736665Authors
		Edgar V. Lerma, University of Illinois at Chicago College of Medicine/Associates in Nephrology Section of Nephrology Chicago IL
	

	
		Journal Clinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644
	
		Journal Volume Volume 5
	
		Journal Issue Volume 5, Number 1 / December, 2007 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=991983</comments>
            <pubDate>Mon, 29 Oct 2007 14:36:12 +0100</pubDate>
            <guid isPermaLink="false">991983</guid>        </item>
        <item>
            <title>Pathophysiology of renal osteodystrophy</title>
            <link>http://www.medworm.com/index.php?rid=991982&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fmku706nk002v6n6j%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Renal osteodystrophy is a common complication of chronic Kidney disease, and abnormalities of bone metabolism are a reflection
 of broad-based disturbances in the control mechanisms for mineral metabolism. Secondary hyperparathyroidism is a major contributor
 to the high turnover form of renal osteodystrophy. Detailed investigations over the past several decades have uncovered many
 of the mechanisms involved in the initiation and maintenance of secondary hyperparathyroidism and it is these mechanisms that
 provide the basis for therapeutic intervention to control this complication of chronic kidney disease. An additional form
 of renal osteodystropy is characterized by abnormally low bone turnover, which also is multi-factorial in origin. Again, an
 understanding of th...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=991982</comments>
            <pubDate>Mon, 29 Oct 2007 14:36:12 +0100</pubDate>
            <guid isPermaLink="false">991982</guid>        </item>
        <item>
            <title>Acknowledgments</title>
            <link>http://www.medworm.com/index.php?rid=991979&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl168q47832015tg7%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/BF02736672Authors
		Edgar V. Lerma, University of Illinois at Chicago College of Medicine/Associates in Nephrology Section of Nephrology Chicago IL
	

	
		Journal Clinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644
	
		Journal Volume Volume 5
	
		Journal Issue Volume 5, Number 1 / December, 2007 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=991979</comments>
            <pubDate>Mon, 29 Oct 2007 14:36:12 +0100</pubDate>
            <guid isPermaLink="false">991979</guid>        </item>
        <item>
            <title>The Molecular Mechanisms of Action of Bisphosphonates</title>
            <link>http://www.medworm.com/index.php?rid=974625&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj21656p6wpx74731%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;BPs can be grouped into two general classes according to their chemical structure and the molecular mechanism by which they
 inhibit osteoclast-mediated bone resorption. The simple BPs can be metabolically incorporated into non-hydrolysable analogues
 of ATP that accumulate intracellularly in osteoclasts, causing osteoclast cell death by apoptosis. By contrast, the more potent
 N-BPs inhibit FPP synthase, an enzyme in the mevalonate pathway. Inhibition of this enzyme in osteoclasts prevents the biosynthesis
 of isoprenoid lipids that are required for the prenylation of small GTPase signalling proteins necessary for osteoclast function.
 Inhibition of FPP synthase in cells other than osteoclasts also appears to account for the adverse effects of N-BPs in&amp;nbsp;vivo
 (incl...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=974625</comments>
            <pubDate>Sun, 21 Oct 2007 00:09:41 +0100</pubDate>
            <guid isPermaLink="false">974625</guid>        </item>
        <item>
            <title>Bisphosphonates in Osteogenesis Imperfecta</title>
            <link>http://www.medworm.com/index.php?rid=947441&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh45u448l67510lp0%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Osteogenesis Imperfecta (OI) is a rare heritable condition characterized by bone fragility and reduced bone mass. Most affected
 individuals carry a mutation that compromises the synthesis and/or the structural organization of type I collagen. Histologically
 there is a picture of osteoporosis with increased remodeling rate. On that basis, bisphosphonate treatment was introduced,
 and definite benefits, in terms of pain control, fracture incidence and degree of ambulation, became rapidly evident. Cyclical
 intravenous pamidronate is now the standard of care for moderate/severe OI in combination with appropriate orthopedic corrections
 and rehabilitation programs. While it is amply demonstrated that the use of bisphosphonates in OI is effective and safe for
 the short te...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=947441</comments>
            <pubDate>Thu, 11 Oct 2007 15:11:16 +0100</pubDate>
            <guid isPermaLink="false">947441</guid>        </item>
        <item>
            <title>Bisphosphonates in Advanced Malignant Disease</title>
            <link>http://www.medworm.com/index.php?rid=941932&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5m14429554711584%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Tumor-induced osteolysis is responsible for a considerable morbidity and often dramatically alters patients’ quality of life.
 Bone destruction is essentially mediated by the osteoclasts, the formation and activity of which are stimulated by tumor secretory
 products. Bisphosphonates are able to interrupt the vicious circle between metastatic cancer cells and bone cells/bone matrix
 by inducing osteoclast apoptosis. For breast cancer patients with metastatic disease and radiographic evidence of bone destruction,
 current guidelines consist in the administration of either pamidronate 90&amp;nbsp;mg over 2&amp;nbsp;h or zoledronic acid 4&amp;nbsp;mg over 15&amp;nbsp;min
 every 3–4&amp;nbsp;weeks. Other bisphosphonates were not considered. Nevertheless, placebo-controlled trials have esta...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=941932</comments>
            <pubDate>Tue, 09 Oct 2007 15:34:04 +0100</pubDate>
            <guid isPermaLink="false">941932</guid>        </item>
        <item>
            <title>Bisphosphonates in Paget’s Disease of Bone</title>
            <link>http://www.medworm.com/index.php?rid=941931&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fmg73275r83104274%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Paget’s disease of bone is a chronic focal bone remodeling disorder with distinctive geographic occurnece. In the US, 1.8%
 of people over 60 years of age are affected. At present, 70% of patients are asymptomatic with the most common presenting
 symptoms being bone pain, osteoarthritis, and bone deformity. Paget’s disease is usually easily diagnosed by an elevated serum
 alkaline phosphatase level, a bone scan and skeletal radiographs of area that show increased activity on the bone scan. There
 is no cure for this disorder; however, a class of drugs, the bisphosphoates, can control the elevated bone remodeling rates,
 improve osteolytic skeletal lesions and attendant bone pain. The most effective bisphosphonates are the nitrogen-containing
 compounds, which can be...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=941931</comments>
            <pubDate>Tue, 09 Oct 2007 15:34:04 +0100</pubDate>
            <guid isPermaLink="false">941931</guid>        </item>
        <item>
            <title>Adverse Effects of Drugs on Bone and Calcium Metabolism/Physiology</title>
            <link>http://www.medworm.com/index.php?rid=912074&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc702513425x27142%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Drugs may affect bone turnover and density in many ways. However, the disease for which the drugs are administered may also
 contribute to bone loss. Infection with human immunodeficiency virus leads to a loss of bone mineral, while treatment with
 highly active antiretroviral therapy does not seem to contribute to further bone loss. Type 1 diabetes is associated with
 a decrease in bone mineral, while type 2 diabetes is associated with an increase. The new class of thiazolidinediones (glitazones)
 has been associated with an increased loss of bone mineral. In breast cancer treatment, tamoxifen is associated with an increased
 bone mineral, while the newer class of aromatase inhibitors through a decrease in serum oestradiol are associated with an
 increased loss of bone...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=912074</comments>
            <pubDate>Thu, 27 Sep 2007 15:43:47 +0100</pubDate>
            <guid isPermaLink="false">912074</guid>        </item>
        <item>
            <title>Bisphosphonates in Corticosteroid-Induced Osteoporosis</title>
            <link>http://www.medworm.com/index.php?rid=882923&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Far68q43838106585%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Corticosteroid osteoporosis is a common clinical problem with the risk of fracture, highest in postmenopausal women. The first
 choice for prevention is a potent oral bisphosphonate such as alendronate or risedronate. In patients intolerant of oral bisphosphonates,
 intravenous bisphosphonates should be used. Prophylactic therapy should be continued whilst patients continue significant
 doses of corticosteroid therapy. In patients receiving chronic low-dose corticosteroids where the BMD is substantially reduced,
 other therapies such as PTH should be considered, followed by a bisphosphonate.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12018-007-9000-4Authors
		Philip N. Sambrook, University of Sydney, Royal North Shore Hospital Institute of Bone a...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=882923</comments>
            <pubDate>Fri, 14 Sep 2007 19:31:25 +0100</pubDate>
            <guid isPermaLink="false">882923</guid>        </item>
        <item>
            <title>Surgical management of hyperparathyroidism in renal failure</title>
            <link>http://www.medworm.com/index.php?rid=865627&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ftv4401071v352837%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In the setting of renal disease and hyperparathyroidism, a near total parathyroidectomy with cryopreservation is a safe and
 effective treatment. Even with improved dialysis and medical management, parathyroid surgery remains effective therapy for
 patients with hyperparathyroidism associated with renal failure. Symptomatic patients particularly need to be identified earlier
 for parathyroidectomy to prevent progression of bone disease in chronic renal failure.
 
	Content Type Journal ArticleDOI 10.1007/s12018-007-0006-8Authors
		Jyotirmay Sharma, Emory University Department of General Surgery 1365 Clifton Atlanta GA 30322 USACollin J. Weber, Emory University Department of Surgery/Research 101 Woodruff Circle, Suite 5105 Atlanta GA 30322 USA
	

	
		Journal Clinical Revi...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=865627</comments>
            <pubDate>Tue, 11 Sep 2007 08:12:26 +0100</pubDate>
            <guid isPermaLink="false">865627</guid>        </item>
        <item>
            <title>Historical Perspectives on Parathyroid Surgery</title>
            <link>http://www.medworm.com/index.php?rid=841847&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu622727u75058481%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The field of parathyroid surgery is rich in history. It begins with an obscure publication by a Swedish medical student noting
 a distinct anatomic entity in the neck adjacent to the thyroid gland; these tiny glands would come to be known as the parathyroid
 glands. This was followed by the subsequent discovery of their role in calcium metabolism, once the devastating effects of
 hyperparathyroidism on the bones and kidneys were recognized. The first neck explorations with identification and removal
 of parathyroid adenomas took place in the early twentieth century. Following the initial parathyroid operations in the United
 States and Europe, the mid-twentieth century was dominated by extensive investigation into calcium metabolism and the effects
 of parathyroid hormo...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=841847</comments>
            <pubDate>Tue, 04 Sep 2007 14:47:24 +0100</pubDate>
            <guid isPermaLink="false">841847</guid>        </item>
        <item>
            <title>Antiepileptic drugs and bone disease</title>
            <link>http://www.medworm.com/index.php?rid=823644&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2l73m72g732422t2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Numerous studies have provided evidence of an association between antiepileptic drugs (AEDs) and adverse effects. Manifestations
 of bone disease in persons treated with AEDs include rickets, osteomalacia, osteoporosis, and fracture. There exists pathological
 and radiographic evidence of bone disease in persons with epilepsy treated with AEDs. As well, numerous biochemical abnormalities
 have been described including hypocalcemia, hypophosphatemia, reduced levels of biologically active vitamin D metabolites,
 hyperparathyroidism, and accelerated bone turnover, as measured by markers of bone formation and bone resorption. The AEDs
 most commonly reported as affecting bone include inducers of the cytochrome P450 enzyme system (phenytoin, phenobarbital,
 primidone, carbam...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=823644</comments>
            <pubDate>Sun, 26 Aug 2007 08:32:40 +0100</pubDate>
            <guid isPermaLink="false">823644</guid>        </item>
        <item>
            <title>Effects of thyroid hormone on bone</title>
            <link>http://www.medworm.com/index.php?rid=823646&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F97079238p7t84263%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;It is relatively well established that thyroid hormone has a clinically significant effect on bone. Although some aspects,
 such as the bone mineral loss associated with overt thyrotoxicosis have been relatively well described, others remain much
 less clear. A major focus of this review is on the effects of chronic exogenous thyroid hormone administration on bone physiology.
 When thyroid hormone dosage is supraphysiologic, an iatrogenic clinical model is produced comparable to endogenous “subclinical
 hyperthyroidism”. Indeed, literature on bone mineral changes in the latter entity may be analyzed as representative of effects
 of excessive circulating thyroid hormone. At the molecular level, thyroid hormone receptors as well as thyroid-stimulating
 hormone (TSH) r...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=823646</comments>
            <pubDate>Sun, 26 Aug 2007 08:32:39 +0100</pubDate>
            <guid isPermaLink="false">823646</guid>        </item>
        <item>
            <title>Effects of drug treatment for malignancy on skeletal health of cancer survivors</title>
            <link>http://www.medworm.com/index.php?rid=823645&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq870673271546045%2F</link>
            <description>This article
 focuses on therapy for breast cancer and other malignancies and the respective contributions of such therapy to bone loss.
 
	Content TypeJournal Article

	
		JournalClinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644
	
		Journal VolumeVolume 2
	
		Journal IssueVolume 2, Number 2 / June, 2004 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=823645</comments>
            <pubDate>Sun, 26 Aug 2007 08:32:39 +0100</pubDate>
            <guid isPermaLink="false">823645</guid>        </item>
        <item>
            <title>Treatment-related osteoporosis in men with prostate cancer</title>
            <link>http://www.medworm.com/index.php?rid=823643&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1736p28864516481%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Osteoporosis is an important complication of androgen-deprivation therapy (ADT) for prostate cancer. ADT by either bilateral
 orchiectomies or treatment with a gonadotropin-releasing hormone (GnRH) agonist decreases bone mineral density (BMD) and increases
 the risk of fracture. Prospective data about treatment or prevention of osteoporosis in men with prostate cancer are limited.
 Supplemental calcium and vitamin D are recommended. Additional therapy may be warranted for men with osteoporosis or fractures.
 Intravenous pamidronate prevents bone loss in the hip and spine during ADT. Intravenous zoledronic acid not only prevents
 bone loss but also increases BMD. Alendronate is approved to treatmen with osteoporosis although the efficacy of alendronate
 or other oral bis...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=823643</comments>
            <pubDate>Sun, 26 Aug 2007 08:32:39 +0100</pubDate>
            <guid isPermaLink="false">823643</guid>        </item>
        <item>
            <title>Effects of anticoagulants on bone</title>
            <link>http://www.medworm.com/index.php?rid=823641&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr351tm5l35504126%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The anticoagulants heparin and sodium warfarin (4-hydroxycoumarin) are commonly used as antithrombotic agents. However, their
 long-term use has been linked to a variety of adverse effects on the skeleton, including warfarin-induced embryopathy and
 osteoporosis. Although both heparin and warfarin have been reported to decrease bone density, the mechanisms responsible for
 bone loss have not yet been fully elucidated. Recent studies with experimental animals have suggested that these agents act
 on bone to decrease the rate of bone formation while increasing the rate of bone resorption. In addition, such studies along
 with a number of clinical trials suggest that the risk of developing osteoporosis may be lower with low-molecular-weight heparins
 than it is with hepari...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=823641</comments>
            <pubDate>Sun, 26 Aug 2007 08:32:39 +0100</pubDate>
            <guid isPermaLink="false">823641</guid>        </item>
        <item>
            <title>Hormonal contraception and bone mineral density</title>
            <link>http://www.medworm.com/index.php?rid=823638&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fhm814104k1220433%2F</link>
            <description>This article offers a review of the relevant literature over the past decade on the relationship between bone mineral density
 (BMD) and selected forms of hormonal contraception, specifically, depot medroxyprogesterone (DMPA) and oral contraceptives
 (OC) in women younger than 30 yr of age. In summary, findings to date suggest an adverse impact of DMPA and ultra-low-dose
 (20 μg ethinyl estradiol) OCs on BMD in young women. The effects appear independent of age; however, the acquisition of optimal
 peak bone mass, particularly in adolescents, may be impeded in young women utilizing these types of hormonal contraception.
 Several mitigating issues also need to be considered in evaluating prescription of DMPA and OCs in young women. These include
 the following: (1) likelihood of at least p...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=823638</comments>
            <pubDate>Sun, 26 Aug 2007 08:32:39 +0100</pubDate>
            <guid isPermaLink="false">823638</guid>        </item>
        <item>
            <title>Nonsteroid immunosuppressive agents and bone</title>
            <link>http://www.medworm.com/index.php?rid=823642&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fgn8277066g3n9856%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The immunosuppressive agents introduced to enhance the action of glucocorticoids and to prevent organ rejection had a dramatic
 impact on reducing the incidence of organ rejection, enhancing donor organ, and hence patient survival following transplantation.
 However, these agents, cyclosporine and tacrolimus, termed calcineurin inhibitors (CIs) also have side effects, including the promotion of rapid and severe bone loss in vivo experimentally as well as clinically.
 The mechanism at present accounting for this action is unclear, but the role of the T lymphocyte in vivo is essential for
 the process of bone loss. Other immune-modifying drugs, such as az athioprine, mycophenolate mofetil, and sirolimus, which
 are used in conjunction with glucocorticoids and the CIs have...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=823642</comments>
            <pubDate>Sun, 26 Aug 2007 08:32:38 +0100</pubDate>
            <guid isPermaLink="false">823642</guid>        </item>
        <item>
            <title>Glucocorticoid-induced osteoporosis</title>
            <link>http://www.medworm.com/index.php?rid=823640&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F87081h158p2w8w7u%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Glucocorticoid-induced osteoporosis is the leading cause of medication-induced osteoporosis. The fracture incidence after
 1 yr of glucocorticoid therapy has been found to be 17% and observational studies suggest that fractures eventually occurin
 30 to 50% of chronic glucocorticoid-treated patients. An increased risk of fracture develops within as quickly as 3 mo, and
 with doses of prednisone as low as 2.5 mg daily. Despite effective methods of prevention and treatment, only 50% of chronic
 glucocoriticoid-treated patients undergo any evaluation for osteoporosis and less than one in four receives treatment. This
 article addresses the various issues the clinician faces in managing patients receiving chronic glucocorticoids. It begins
 and ends with a case perspective....</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=823640</comments>
            <pubDate>Sun, 26 Aug 2007 08:32:38 +0100</pubDate>
            <guid isPermaLink="false">823640</guid>        </item>
        <item>
            <title>Osteoporosis in HIV-infected patients</title>
            <link>http://www.medworm.com/index.php?rid=823639&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0177k8742x480344%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Bone disorders have emerged in the last 5 yr as additional long-term complications of human immunodeficiency virus (HIV) infection
 and its treatment. In particular, multiple studies suggest that HIV-infected patients receiving potent antiretroviral therapy
 have an increased prevalence of both osteopenia and osteoporosis. Studies prior to the era of potent antiretroviral therapy
 suggest that HIV infection has a modest effect on bone turnover. Treatment of HIV increases bone turnover with a greater effect
 on bone resorption. The mechanisms for increased bone demineralization in HIV-infected patients are unclear, although there
 is some evidence that specific drugs may inhibit bone formation in vitro. Small studies suggest that, in general, bone loss
 is not progressiv...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=823639</comments>
            <pubDate>Sun, 26 Aug 2007 08:32:37 +0100</pubDate>
            <guid isPermaLink="false">823639</guid>        </item>
        <item>
            <title>Normal calcium homeostasis</title>
            <link>http://www.medworm.com/index.php?rid=778953&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv6281675r6523361%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;This introduction to normal calcium provides a basis for an understanding of the investigation of calcium disorders, which
 now follows.
 
	Content TypeJournal Article

	
		JournalClinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644
	
		Journal VolumeVolume 1
	
		Journal IssueVolume 1, Number 1 / March, 2002 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=778953</comments>
            <pubDate>Thu, 02 Aug 2007 06:59:50 +0100</pubDate>
            <guid isPermaLink="false">778953</guid>        </item>
        <item>
            <title>Hypercalcemia</title>
            <link>http://www.medworm.com/index.php?rid=778950&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl1t14748j8u85426%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The etiology of hypercalcemia can be clearly defined in the majority of patients by following a simple diagnostic algorithm
 outlined in Fig. 1. The performance and interpretation of analytical methods, now routinely available within diagnostic laboratories,
 has improved considerably within the last decade. These developments have improved our ability to diagnose the cause of hypercalcemia
 with confidence. Consequently, it should be possible to determine whether the hypercalcemia, in an individual patients, is
 mediated principally by the bowel, kidney, or bone compartment. Armed with this information and with the advent of novel,
 more selective therapeutic agents, treatment prescriptions in the future may be more appropriately tailored to each individual
 case.
 ...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=778950</comments>
            <pubDate>Thu, 02 Aug 2007 06:59:50 +0100</pubDate>
            <guid isPermaLink="false">778950</guid>        </item>
        <item>
            <title>Other causes of hypercalcemia</title>
            <link>http://www.medworm.com/index.php?rid=778936&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc2281610k6821261%2F</link>
            <description>Content TypeJournal Article

	
		JournalClinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644
	
		Journal VolumeVolume 1
	
		Journal IssueVolume 1, Number 1 / March, 2002 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=778936</comments>
            <pubDate>Thu, 02 Aug 2007 06:59:50 +0100</pubDate>
            <guid isPermaLink="false">778936</guid>        </item>
        <item>
            <title>Familial benign hypocalciuric hypercalcemia and neonatal hyperparathyroidism</title>
            <link>http://www.medworm.com/index.php?rid=778954&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F406303r5525w8500%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;In summary, both FBHH and NSHPT represent the phenotypic expression of inactivating mutations of the CaSR in most cases, FBHH
 usually presenting with mild asymptomatic lifelong hypercalcemia and NSHPT with generally more severe, potentially lethal
 hypercalcemia, which, in cases of homozygous or compound heterozygous CaSR mutations, carries a high morbidity. Additional
 molecular studies should elucidate the basis for variations in the phenotypic and biochemical abnormalities observed with
 both FBHH and NSHPT and identify the disease genes on chromosome 19 that can also cause FBHH in rare cases.
 
	Content TypeJournal Article

	
		JournalClinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644
	
		Journal VolumeVolume 1
	
		Journal Is...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=778954</comments>
            <pubDate>Thu, 02 Aug 2007 06:59:49 +0100</pubDate>
            <guid isPermaLink="false">778954</guid>        </item>
        <item>
            <title>Management of malignancy-associated hypercalcemia</title>
            <link>http://www.medworm.com/index.php?rid=778951&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu5ql57483l823j01%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Rehydration and bisphosphonates represent the mainstay of the management of hypercalcemia associated with malignancy with
 successful achievement of normocalcemia in some 90% of patients. New experimental approaches are currently being tested. and
 the antiosteoclastic potential of osteoprotegrin appars to be promising.
 
	Content TypeJournal Article

	
		JournalClinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644
	
		Journal VolumeVolume 1
	
		Journal IssueVolume 1, Number 1 / March, 2002 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=778951</comments>
            <pubDate>Thu, 02 Aug 2007 06:59:49 +0100</pubDate>
            <guid isPermaLink="false">778951</guid>        </item>
        <item>
            <title>Primary hyperparathyroidism</title>
            <link>http://www.medworm.com/index.php?rid=778949&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb2825480u5448662%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Primary hyperparathyroidism remains a controversial disease, in part because of continuing uncertainty about its effects on
 neuropsychiatric function and risk of vascular events. Several observational studies have now demonstrated low rates of morbid
 events in patients with untreated, mild PHPT. It is this author's opinion that patients with mild PHPT who do not have recognized
 complications of the disease (renal stones or osteopenia) may be managed expectantly, with annual biochemical review and less
 frequent bone density assessments, until more conclusive data are available on other putative associations. Osteopenic patients
 with PHPT can be effectively treated either with surgery or antiresorptive agents, although the presence of renal stones at
 diagnosis is...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=778949</comments>
            <pubDate>Thu, 02 Aug 2007 06:59:49 +0100</pubDate>
            <guid isPermaLink="false">778949</guid>        </item>
        <item>
            <title>Primary hyperparathyroidism</title>
            <link>http://www.medworm.com/index.php?rid=778947&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft147741324576513%2F</link>
            <description>Summary&amp;nbsp;&amp;nbsp;The earliest clinical descriptions of primary hyperparathyroidism pointed to an inexorably progressive disorder. Now, in asymptomatic
 individuals who do not meet any surgical guidelines, primary hyperparathyroidism, in general, does not appear to be progressive.
 Asymptomatic patients appear to remain asymptomatic over many years of observation. In those with major clinical manifestations,
 nephrolithiasis is, by far, the most common. In these patients, surgery is clearly indicated. Bone densitometry is an indispensable
 component of the evaluation as well as in monitoring in that there is evidence for bone involvement by this technology in
 most patients. This contrasts with the skeletal X-ray, which is invariably negative. Nevertheless, only the unusual patients
 will...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=778947</comments>
            <pubDate>Thu, 02 Aug 2007 06:59:49 +0100</pubDate>
            <guid isPermaLink="false">778947</guid>        </item>
        <item>
            <title>Evolution of the clinical presentation of Paget's disease of bone</title>
            <link>http://www.medworm.com/index.php?rid=778941&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fjm7g71531u2g3hu5%2F</link>
            <description>Content TypeJournal Article

	
		JournalClinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644
	
		Journal VolumeVolume 1
	
		Journal IssueVolume 1, Number 2 / June, 2002 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=778941</comments>
            <pubDate>Thu, 02 Aug 2007 06:59:49 +0100</pubDate>
            <guid isPermaLink="false">778941</guid>        </item>
        <item>
            <title>Surgical management of hyperparathyroidism</title>
            <link>http://www.medworm.com/index.php?rid=778939&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3j71426gr4m095g2%2F</link>
            <description>Content TypeJournal Article

	
		JournalClinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644
	
		Journal VolumeVolume 1
	
		Journal IssueVolume 1, Number 1 / March, 2002 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=778939</comments>
            <pubDate>Thu, 02 Aug 2007 06:59:49 +0100</pubDate>
            <guid isPermaLink="false">778939</guid>        </item>
        <item>
            <title>Hypercalcemia of malignancy</title>
            <link>http://www.medworm.com/index.php?rid=778938&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk38u5t86g6230ux8%2F</link>
            <description>Content TypeJournal Article

	
		JournalClinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644
	
		Journal VolumeVolume 1
	
		Journal IssueVolume 1, Number 1 / March, 2002 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=778938</comments>
            <pubDate>Thu, 02 Aug 2007 06:59:49 +0100</pubDate>
            <guid isPermaLink="false">778938</guid>        </item>
        <item>
            <title>Pathogenesis of Paget's disease of bone</title>
            <link>http://www.medworm.com/index.php?rid=778952&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F923g372812155277%2F</link>
            <description>Content TypeJournal Article

	
		JournalClinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644
	
		Journal VolumeVolume 1
	
		Journal IssueVolume 1, Number 2 / June, 2002 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=778952</comments>
            <pubDate>Thu, 02 Aug 2007 06:59:48 +0100</pubDate>
            <guid isPermaLink="false">778952</guid>        </item>
        <item>
            <title>Pharmacological management of Paget's disease of bone</title>
            <link>http://www.medworm.com/index.php?rid=778946&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr15p420l68240220%2F</link>
            <description>Content TypeJournal Article

	
		JournalClinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644
	
		Journal VolumeVolume 1
	
		Journal IssueVolume 1, Number 2 / June, 2002 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=778946</comments>
            <pubDate>Thu, 02 Aug 2007 06:59:48 +0100</pubDate>
            <guid isPermaLink="false">778946</guid>        </item>
        <item>
            <title>The pagetic lesion</title>
            <link>http://www.medworm.com/index.php?rid=778945&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1064wn53620111m1%2F</link>
            <description>Content TypeJournal Article

	
		JournalClinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644
	
		Journal VolumeVolume 1
	
		Journal IssueVolume 1, Number 2 / June, 2002 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=778945</comments>
            <pubDate>Thu, 02 Aug 2007 06:59:48 +0100</pubDate>
            <guid isPermaLink="false">778945</guid>        </item>
        <item>
            <title>Neurological complications of Paget's disease</title>
            <link>http://www.medworm.com/index.php?rid=778944&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh07v5523643t48x7%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The neurologic complications of Paget's disease are infrequent but can be severe and are often treatable. Paget's disease
 should be considered as a posible cause of neurologic symptoms, including those with previously undiagnosed disease. Routine
 neurological assessments should be performed at regular intervals in patients with known Paget's disease of the spine or cranium.
 The outcome of treatment, particularly in cases of spinal cord compression or hydrocephalus, are particularly rewarding. Treatment
 should be based on each individual patient's presentation and consists of symptomatic treatment, antiresorptive therapy, or
 surgery. The latter can frequently be avoided in patients with slow onset spinal cord compression in whom the acute and long-term
 response ...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=778944</comments>
            <pubDate>Thu, 02 Aug 2007 06:59:48 +0100</pubDate>
            <guid isPermaLink="false">778944</guid>        </item>
        <item>
            <title>Introduction</title>
            <link>http://www.medworm.com/index.php?rid=778943&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa411951n023hw250%2F</link>
            <description>Content TypeJournal Article

	
		JournalClinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644
	
		Journal VolumeVolume 1
	
		Journal IssueVolume 1, Number 2 / June, 2002 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=778943</comments>
            <pubDate>Thu, 02 Aug 2007 06:59:48 +0100</pubDate>
            <guid isPermaLink="false">778943</guid>        </item>
        <item>
            <title>Orthopedic surgery considerations in Paget's disease of bone</title>
            <link>http://www.medworm.com/index.php?rid=778942&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F225123461k81j5u4%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Internal fixation in Paget's disease is often necessary for the management of Pagetic complications. When possible, medical
 therapy should be attempted prior to surgical consideration, If surgery is required, preoperative treatment with bisphosphonates
 or calcitonin should be initiated to help reduce intraoperative bleeding. Surgeons should be aware of the increased morbidity
 and mortality of these patients.
 
 Through medical and physical therapy modalities available to all physicians and through the judicious use of surgery in selected
 cases, the orthopedic surgeon is often able to preserve and restore function in this common disorder.
 
 
 
	Content TypeJournal Article

	
		JournalClinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 15...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=778942</comments>
            <pubDate>Thu, 02 Aug 2007 06:59:48 +0100</pubDate>
            <guid isPermaLink="false">778942</guid>        </item>
        <item>
            <title>Radiographic diagnosis and laboratory evaluation of Paget's disease of bone</title>
            <link>http://www.medworm.com/index.php?rid=778940&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fql81063763k83330%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The structural and biological characteristics of Paget's disease are reflected in the radiographic and biochemical tests described
 above. Appropriate use of these tests permits reliable initial diagnostic assessment of Paget's disease and ongoing monitoring
 of its progression and response to treatment.
 
	Content TypeJournal Article

	
		JournalClinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644
	
		Journal VolumeVolume 1
	
		Journal IssueVolume 1, Number 2 / June, 2002 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=778940</comments>
            <pubDate>Thu, 02 Aug 2007 06:59:48 +0100</pubDate>
            <guid isPermaLink="false">778940</guid>        </item>
        <item>
            <title>Emerging concepts of hearing loss in Paget's disease of bone</title>
            <link>http://www.medworm.com/index.php?rid=778948&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg3414825u370l344%2F</link>
            <description>Content TypeJournal Article

	
		JournalClinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644
	
		Journal VolumeVolume 1
	
		Journal IssueVolume 1, Number 2 / June, 2002 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=778948</comments>
            <pubDate>Thu, 02 Aug 2007 06:59:47 +0100</pubDate>
            <guid isPermaLink="false">778948</guid>        </item>
        <item>
            <title>Epidemiology of Paget's disease of bone</title>
            <link>http://www.medworm.com/index.php?rid=778937&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F87196t03506ph115%2F</link>
            <description>Content TypeJournal Article

	
		JournalClinical Reviews in Bone and Mineral MetabolismOnline ISSN 1559-0119Print ISSN 1534-8644
	
		Journal VolumeVolume 1
	
		Journal IssueVolume 1, Number 2 / June, 2002 (Source: Clinical Reviews in Bone and Mineral Metabolism)</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=778937</comments>
            <pubDate>Thu, 02 Aug 2007 06:59:47 +0100</pubDate>
            <guid isPermaLink="false">778937</guid>        </item>
        <item>
            <title>Parathyroidectomy: Overview of the Anatomic Basis and Surgical Strategies for Parathyroid Operations</title>
            <link>http://www.medworm.com/index.php?rid=778955&amp;cid=s_35924_49_f&amp;fid=35924&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7094h63251671784%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;It is imperative for the surgeon who performs parathyroidectomy to have a thorough understanding of the anatomy and embryology
 of the parathyroid glands in order to optimize the cure rate for patients with hyperparathyroidism (HPT). Furthermore, all
 clinicians caring for patients with hyperparathyroidism should be aware of the advancements in preoperative parathyroid localization,
 intraoperative PTH monitoring and surgical strategies for treatment of hyperparathyroidism. In this chapter, the anatomy and
 embryology of the parathyroid glands will be reviewed. The available surgical options for treatment of patients with hyperparathyroidism
 will be addressed, including “focused” parathyroidectomy, bilateral neck exploration, radioguided parathyroidectomy, and endo...</description>
            <author>Clinical Reviews in Bone and Mineral Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=778955</comments>
            <pubDate>Fri, 13 Jul 2007 11:30:27 +0100</pubDate>
            <guid isPermaLink="false">778955</guid>        </item>
    </channel>
</rss>
